The effects of peripherally administered 6-hydroxydopamine on rat brain monoamine turnover.
D000081:Acetamides / Q000494:pharmacology; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D001923:Brain Chemistry; D002395:Catecholamines / Q000037:antagonists & inhibitors*; D002396:Catechols / Q000494:pharmacology; D004220:Disulfides / Q000494:pharmacology; D004298:Dopamine / Q000032:analysis / Q000378:metabolism* / Q000494:pharmacology; D007093:Imidazoles / Q000494:pharmacology; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D009206:Myocardium / Q000032:analysis; D009638:Norepinephrine / Q000032:analysis / Q000378:metabolism*; D051381:Rats; D011919:Rats, Inbred Strains; D012701:Serotonin / Q000032:analysis / Q000378:metabolism*; D013564:Sympathetic Nervous System / Q000502:physiology
D000081:Acetamides; D002395:Catecholamines; D002396:Catechols; D004220:Disulfides; D007093:Imidazoles; D008781:Methyltyrosines; D012701:Serotonin; D004298:Dopamine; D009638:Norepinephrine